Securing Our Schools Act of 2018

21st Century Cures Act 2.0 340B Drug Discount Program Advanced Research Projects Agency for Health (ARPA-H) AMP Cap Biosimilar approval and reimbursement policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions BLOCKING Act Buy American and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients Cell, gene and radioligand therapies Comprehensive Immunosuppressant Drug Coverage for Kidney Transplant Patients Act of 2020 Co-pay accumulator programs COVID-19 Defense Production Act Diversity in Clinical Trials Drug cost and pricing policy issues Drug Importation and counterfeiting policy issues Drug shortages policy issues Drug vial size policy issues FDA modernization policy issues Foreign manufacturing policy issues Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement FY 2022 Labor-HHS Appropriations H.R.1319, American Rescue Plan Act of 2021 H.R.133, Consolidated Appropriations Act for FY 2021 H.R.2815, The BIOSIM Act H.R.2855, Star Rating for Biosimilars Act H.R.3, Elijah E. Cummings Lower Drug Costs Now Act H.R.5463, Drug Pricing Transparency and Accountability Act H.R. 5260, Reduced Costs and Continued Cures Act H.R. 4811, Medicare Negotiation and Competitive Licensing Act of 2021 Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Medicaid Generics Penalty Fix Medicaid Payment Reform Notice of Benefit Payment Parameters (NBPP) Orphan Drugs Outcomes based contracting/value based arrangements Part B Home Infusion Patient assistance program policy issues PDUFA, BSUFA, GDUFA Pharmaceutical quality Pharmaceutical supply chain H.R.5388/S.2740 PREPARE ACT of 2021 (API stockpiling) Priority Review Voucher (PRV) Regulatory efficiencies policy issues S.1427, HR 2869 - Increasing Access to Biosimilars Act of 2021 S.164, Advancing Education on Biosimilars Act of 2021 Transparency policy issues Vaccines White House National Biodefense Strategy H.R. 5416, The Give Kids a Chance Act HR 5376 Build Back Better Act of 2021 S. 7399 Prevent Pandemics Act HR 19/S. 2164 Lower Costs, More Cures Act of 2021 Healthcare Disparities Accelerated Approval (HR 6963 and HR 6996) Cancer Moonshot Initiative

Client expense: $1,300,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Charter Schools Child Nutrition Civil Rights ESEA (Elementary and Secondary Education Act) Federal Education Association HEA (Higher Education Act) Health Care High School Turnaround/Dropout Prevention Higher Education/Financial Student Loans IDEA (Funding) Labor Issues Literacy Parental Engagement Perkins-CTE Public Service Loan Forgiveness School Construction/Modernization/Green Schools School Safety/Gun Violence School to Prison Pipeline Secure Rural Schools Taxes/Revenue Vouchers/Privatization 94-13930 Senate Committee on Health, Education, Labor, and Pensions House Transportation and Infrastructure Committee HCONRES 114 HR 4909 HR 1625 HR 2353 HR 2913 HR 4508 HR 4536 HR 4811 HR 4909 HR 5199 HR 719 S 2370 S 2517 Environment and Public Works Committee hearing

Client expense: $683,876 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Charter Schools Child Nutrition Civil Rights ESEA (Elementary and Secondary Education Act) Federal Education Association HEA (Higher Education Act) Health Care High School Turnaround/Dropout Prevention Higher Education/Financial Student Loans IDEA (Funding) Labor Issues Literacy Parental Engagement Perkins-CTE Public Service Loan Forgiveness School Construction/Modernization/Green Schools School Safety/Gun Violence School to Prison Pipeline Secure Rural Schools Taxes/Revenue Vouchers/Privatization 94-13930 Senate Committee on Health, Education, Labor, and Pensions House Transportation and Infrastructure Committee HCONRES 114 HR 4909 HR 1625 HR 2353 HR 2913 HR 4508 HR 4536 HR 4811 HR 4909 HR 5199 HR 719 S 2370 S 2517 Environment and Public Works Committee hearing

Client expense: $683,876 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE